8:00 am Morning Check In & Coffee
8:20 am Chair’s Opening Remarks
De-Risking Your Pipelines with Guidance from Regulatory Experts to Realize the Promise of mRNA
8:30 am Discussing the Regulatory Expectations for mRNA-Based Therapeutics & Vaccines Against Infectious Diseases, Cancer & Rare Diseases
9:00 am TFF in RNA Workflow: Process Optimization for mRNA, saRNA, & LNP Manufacturing
9:30 am Panel Discussion: Uniting Regulatory Experts from Industry & Agencies to Navigate the Complex Landscape for mRNA-Based Medicines
10:15 am Empowering the mRNA Industry with Nucleic Acid Therapeutics: Innovating for Success
Synopsis
This presentation offers an exploration of Thermo Fisher Scientific's unrivaled expertise in nucleic acid therapeutics, specifically tailored to support the mRNA industry. It provides a detailed overview of Thermo Fisher Scientific's extensive capabilities and offerings, highlighting their ability to deliver highly impactful solutions in this dynamic and rapidly evolving field. The presentation features an inspiring customer case study, showcasing Thermo Fisher Scientific's successful track record of supporting businesses in the mRNA industry. This real-life example serves as a testament to the effectiveness and reliability of Thermo Fisher Scientific's solutions and underscores their commitment to driving progress in the mRNA sector.
10:45 am Morning Networking Break
Discovery
Chair: Denny Kraichely, Global Program Leader, Vaccine Development Management, Pfizer
Download the Full Event Guide for full details
Accelerating the Development of Personalized & Prophylactic mRNA-Based Vaccines & Therapeutics to Fight Infectious & Oncological Diseases
11:15am Advancing Immunoinformatic Tools for Epitope Mapping to Supercharge Development of mRNA-Based Personalized Cancer Vaccines
Download the Full Event Guide for full details
Guilhem Richard, Head of Innovation and Technology, EpiVax, Inc.
11:45am Radar Therapeutics: Pioneering Precision-Expressed mRNA Therapeutics
Download the Full Event Guide for full details
Sophia Lugo, Chief Executive Officer, Radar Therapeutics
12:15pm Innovac’s End-To-End Approach to Capitalize on the mRNA Revolution in the Vaccine Industry
Download the Full Event Guide for full details
Nicholas Valiante, Co-Founder & Chief Scientific Officer, Innovac Therapeutics New Company!
12:45 pm Lunch & Networking Break
Discovery
Elucidating the Fate of the mRNA Payload Inside the Cell for Increased Delivery Efficiency & Expression
1:45pm Decoding the Dance: Unravelling the Moves of LNP-mRNA-based Vaccines
Download the Full Event Guide for full details
Alisa Zhilin Roth, Senior Scientist, In vitro & Mechanism, Sanofi New Data!